Holdings of Pivotal bioVenture Partners Investment Advisor LLC
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 12 in 1 countries
- Top ten
- 99.1 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | VAXCYTE INC | 1,372,425 | 79.8M $ | |
| 2 | Evommune Inc | 1,926,943 | 44.3M $ | |
| 3 | Arcutis Biotherapeutics Inc | 1,355,892 | 31.9M $ | |
| 4 | Trevi Therapeutics Inc | 1,553,726 | 18.5M $ | |
| 5 | Immunome Inc | 732,512 | 16M $ | |
| 6 | MAPLIGHT THERAPEUTICS INC | 611,447 | 12.4M $ | |
| 7 | ZENAS BIOPHARMA INC | 591,991 | 11.6M $ | |
| 8 | BioAge Labs Inc | 653,374 | 11.4M $ | |
| 9 | AVALO THERAPEUTICS INC | 295,933 | 4.4M $ | |
| 10 | RALLYBIO CORP | 300,579 | 2.7M $ | |
| 11 | Recursion Pharmaceuticals Inc | 595,518 | 1.8M $ | |
| 12 | BOLT BIOTHERAPEUTICS INC | 42,581 | 172K $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 100.0 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 12 | 235.1M $ | 100.00 % |
Cite this page
Titelia. "Holdings of Pivotal bioVenture Partners Investment Advisor LLC". https://titelia.com/en/funds/US13F1844645